EN
HI
Rekvina Laboratories Share price
VINRKLB
43
1.00 (2.38%)Last updated on 21 Aug, 2026 | 16:01 IST
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Rekvina Laboratories share price chart
Rekvina Laboratories Share Key Metrics
Volume
1755.00
Market Cap
25.15 CR
LTQ@LTP
31@43.00
ATP
40.59
Var Margin
100 %
Circuit Range
39.9-44.1
Delivery %
100 %
Value
71235.45
ASM/GSM
No
Market Lot
1
Summary
VINRKLB stock price is ₹43 as of 22 Aug, 2026. The stock intraday movement has stayed between ₹39.90 and ₹43.00, while Rekvina Laboratories share price 52 week high low is ₹6.75 & ₹46.65.
In terms of trading activity, VINRKLB share price has recorded a volume of 1,755 shares. The Rekvina Laboratories has a market cap of ₹6028000. The stock’s Average Traded Price (ATP) stands at ₹40.59, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 31 @ ₹43.00.
The Rekvina Laboratories upper circuit limit is ₹44.10 & The Rekvina Laboratories lower circuit limit is ₹39.90, with a Value of ₹71235.45. The Delivery Percentage for the day is 100%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Rekvina Laboratories Resistance and Support
Pivot 41.54
Resistance
First Resistance
43.46
Second Resistance
44.92
Third Resistance
46.84
Support
First Support
40.08
Second Support
38.16
Third Support
36.7
Rekvina Laboratories Shareholding Pattern
View More- 2016-17
- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Segment
Percent
Total Promoters
41.3%
Mutual Fund
0%
Insurance
0%
Foreign Institutional Investors
0%
Domestic Institutional Investors
0%
Retail
58.7%
Others
0%
Total Promoters
MAR '24
45.09%
JUN '24
41.3%
SEP '24
41.3%
DEC '24
41.3%
Rekvina Laboratories Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-13 | Quarterly Results |
| 2026-05-21 | Audited Results |
| 2026-03-16 | Preferential Issue of shares |
| 2026-02-06 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-08-13 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-30 | Audited Results |
| 2025-01-20 | Quarterly Results |
| 2024-11-14 | Quarterly Results |
| 2024-07-29 | Quarterly Results |
Rekvina Laboratories News
Rekvina Laboratories Ltd - 526075 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Rekvina Laboratories' promoter and PACs significantly increased their shareholding by 31.34%, raising their total stake to 60.30%. This acquisition was executed through a combination of an open offer and preferential allotment, reflecting enhanced promoter confidence and control.
Aug 18 2026 10:41:46
Rekvina Laboratories Ltd - 526075 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
Dhruvalkumar Patel acquired 1,112,562 equity shares in Rekvina Laboratories, bringing his total holding to 10.01% of the company's voting capital. This acquisition was done through a combination of an open offer and preferential allotment on August 12-13, 2026.
Aug 17 2026 15:15:05
Rekvina Laboratories Ltd - 526075 - Board Meeting Outcome for OUTCOME OF BOARD MEETING
Rekvina Laboratories reported a Q1 FY27 standalone net loss of ₹0.12 crore, significantly widening from the ₹0.03 crore loss recorded in Q1 FY26. Additionally, the board appointed Surbhit Shah as the Executive Director and Chairman.
Aug 13 2026 15:47:52
Rekvina Laboratories Ltd - 526075 - Announcement under Regulation 30 (LODR)-Allotment
Rekvina Laboratories allotted 46.28 lakh equity shares on a preferential basis for the acquisition of Radiant Parenterals Limited, which will become a wholly-owned subsidiary. An additional 4.60 lakh shares were allotted for cash consideration of Rs.46 lakh.
Aug 12 2026 17:27:09
Rekvina Laboratories Ltd - 526075 - Board Meeting Intimation for Consideration Of Unaudited Financial Result For The Quarter Ended 30Th June, 2026
Rekvina Laboratories board will convene on August 13, 2026. The primary agenda is to consider and approve the un-audited standalone financial results for the first quarter of FY27.
Aug 01 2026 12:27:25
Rekvina Laboratories Ltd - 526075 - Announcement under Regulation 30 (LODR)-Open Offer - Updates
Rekvina Laboratories announced the completion of its open offer, where acquirers Surbhit Mukesh Shah, Amit Mukesh Shah, and Dhruvalkumar Patel collectively increased their shareholding to 64.30% of the expanded share capital. A total of 1,441,863 shares were accepted at an offer price of Rs.10 each.
Aug 01 2026 12:17:32
Read More
Rekvina Laboratories Management
| Name | Position |
|---|---|
| Amit Shah | Managing Director |
| Deepak Khandelwal | Company Secretary & Compliance Officer |
Rekvina Laboratories Similar Stocks

Rekvina Laboratories FAQs
The Buying Price of Rekvina Laboratories share is 43 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Rekvina Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Rekvina Laboratories, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Rekvina Laboratories shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Rekvina Laboratories shares is 0. Useful to assess the stock's value relative to its book value.
To assess Rekvina Laboratories’s valuation compare Sector P/E, P/B which are 58.07 & 2.15 with sector averages, along with growth rates and financial metrics.
The Market Cap of Rekvina Laboratories is 25.15 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Rekvina Laboratories share price is 46.65 & 6.75. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Rekvina Laboratories belongs to the Miscellaneous sector.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in VINRKLB
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC